Compound details
10-Deacetyltaxol A
| Compound ID | CDAMM02930 |
|---|---|
| Common name | 10-Deacetyltaxol A | IUPAC name | [4-acetyloxy-15-(3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy-1,9,12-trihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate |
| Molecular formula | C45H49NO13 |
| Retention time | 15.72 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 812.324 | Theoretical mz | 812.327 |
| Error | 4.03 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.5071 |
| Inchi key | TYLVGQKNNUHXIP-PLCZGVAUNA-N |
|---|---|
| Smiles | O=C(OC1C2C3(OC(=O)C)COC3CC(O)C2(C(=O)C(O)C4=C(C)C(OC(=O)C(O)C(NC(=O)C=5C=CC=CC5)C=6C=CC=CC6)CC1(O)C4(C)C)C)C=7C=CC=CC7 |
| Superclass | Lipids and lipid-like molecules |
| Class | Prenol lipids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P00533 | EGFR | Epidermal growth factor receptor erbB1 | T59328 | SwissTargetPrediction |
| P29274 | ADORA2A | Adenosine A2a receptor | T77365 | SwissTargetPrediction |
| P30542 | ADORA1 | Adenosine A1 receptor | T92072 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P42338 | PIK3CB | PI3-kinase p110-beta subunit | T05031 | SwissTargetPrediction |
| P08684 | CYP3A4 | Cytochrome P450 3A4 | T37848 | SwissTargetPrediction |
| P43405 | SYK | Tyrosine-protein kinase SYK | T62431 | SwissTargetPrediction |
| Q9NTG7 | SIRT3 | NAD-dependent deacetylase sirtuin 3 | T91959 | SwissTargetPrediction |
| Q8IXJ6 | SIRT2 | NAD-dependent deacetylase sirtuin 2 | T83904 | SwissTargetPrediction |
| P13866 | SLC5A1 | Sodium/glucose cotransporter 1 | T54771 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P21554 | CNR1 | Cannabinoid receptor 1 (by homology) | T76685 | SwissTargetPrediction |
| P07949 | RET | Kinesin-1 heavy chain/ Tyrosine-protein kinase receptor RET | T60631 | SwissTargetPrediction |
| P29275 | ADORA2B | Adenosine A2b receptor | T86679 | SwissTargetPrediction |
| P07384 | CAPN1 | Calpain 1 | T92517 | SwissTargetPrediction |
| Q99705 | MCHR1 | Melanin-concentrating hormone receptor 1 | T09572 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SwissTargetPrediction |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SwissTargetPrediction |
| P17655 | CAPN2 | Calpain 2 | T86837 | SwissTargetPrediction |
| P08069 | IGF1R | Insulin-like growth factor I receptor | T48069 | SwissTargetPrediction |
| Q07817 | BCL2L1 | Apoptosis regulator Bcl-X | T56510 | SwissTargetPrediction |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SwissTargetPrediction and SEA |
| P04626 | ERBB2 | Receptor protein-tyrosine kinase erbB-2 | T14597 | SwissTargetPrediction |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SwissTargetPrediction |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| P30291 | WEE1 | Serine/threonine-protein kinase WEE1 | T69991 | SwissTargetPrediction |
| Q16539 | MAPK14 | MAP kinase p38 alpha | T65864 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SwissTargetPrediction |
| P11802 | CDK4 | Cyclin-dependent kinase 4 | T85799 | SwissTargetPrediction |
| O14965 | AURKA | Serine/threonine-protein kinase Aurora-A | T87675 | SwissTargetPrediction |
| P78536 | ADAM17 | ADAM17 | T82393 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P13497 | BMP1 | Bone morphogenetic protein 1 | T53350 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction |
| P62942 | FKBP1A | FK506-binding protein 1A | T76059 | SwissTargetPrediction |
| P24723 | PRKCH | Protein kinase C eta | T40149 | SwissTargetPrediction |
| P11387 | TOP1 | DNA topoisomerase I | T09826 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | T96623 | SwissTargetPrediction |
| P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | T18477 | SwissTargetPrediction |
| P01375 | TNF | TNF-alpha | T20178 | SwissTargetPrediction |
| P49810 | PSEN2 | Gamma-secretase | T99204 | SwissTargetPrediction |
| Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | T99057 | SwissTargetPrediction |
| O00329 | PIK3CD | PI3-kinase p110-delta subunit | T67849 | SwissTargetPrediction |
| Q15078 | CDK5R1 | Cyclin-dependent kinase 5/CDK5 activator 1 | T09513 | SwissTargetPrediction |
| P12931 | SRC | Tyrosine-protein kinase SRC | T85943 | SwissTargetPrediction |
| Q13627 | DYRK1A | Dual-specificity tyrosine-phosphorylation regulated kinase 1A | T92803 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P29597 | TYK2 | Tyrosine-protein kinase TYK2 | T78932 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| P14091 | CTSE | Cathepsin E | T16891 | SwissTargetPrediction |
| P0DJD9 | PGA5 | Pepsin A | T17863 | SwissTargetPrediction |
| Q96EB6 | SIRT1 | NAD-dependent deacetylase sirtuin 1 | T14731 | SwissTargetPrediction |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SwissTargetPrediction |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SwissTargetPrediction |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SwissTargetPrediction |
| P04629 | NTRK1 | Nerve growth factor receptor Trk-A | T07173 | SwissTargetPrediction |
| P50750 | CDK9 | Cyclin-dependent kinase 9 | T44458 | SwissTargetPrediction |
| Q99558 | MAP3K14 | Mitogen-activated protein kinase kinase kinase 14 | T95736 | SwissTargetPrediction |
| P42574 | CASP3 | Caspase-3 | T57943 | SwissTargetPrediction |
| Q9UQ81 | MCH5 | Caspase-8 | T15700 | SwissTargetPrediction |
| P48736 | PIK3CG | PI3-kinase p110-gamma subunit | T95913 | SwissTargetPrediction |
| P01112 | HRAS | Transforming protein p21/H-Ras-1 | T71081 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P12268 | IMPDH2 | Inosine-5'-monophosphate dehydrogenase 2 | T89360 | SwissTargetPrediction |
| Q9H244 | P2RY12 | Purinergic receptor P2Y12 (by homology) | T46937 | SwissTargetPrediction |
| P78527 | PRKDC | DNA-dependent protein kinase | T81735 | SwissTargetPrediction |
| P56373 | P2RX3 | P2X purinoceptor 3 | T17140 | SwissTargetPrediction |
| P32238 | CCKAR | Cholecystokinin A receptor | T28330 | SwissTargetPrediction |
| Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | T23787 | SwissTargetPrediction |
| O75908 | SOAT2 | Acyl coenzyme A:cholesterol acyltransferase 2 | T14463 | SwissTargetPrediction |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SwissTargetPrediction |
| P60842 | EIF4A1 | Eukaryotic initiation factor 4A-I | T86805 | SwissTargetPrediction |
| P00374 | DHFR | Dihydrofolate reductase | T17345 | SwissTargetPrediction |
| P21452 | TACR2 | Neurokinin 2 receptor | T52790 | SwissTargetPrediction |
| Q07343 | PDE4B | Phosphodiesterase 4B (by homology) | T10265 | SwissTargetPrediction |
| P00746 | CFD | Complement factor D | T66383 | SwissTargetPrediction |
| P48729 | CSNK1A1 | Casein kinase I alpha | T13075 | SwissTargetPrediction |
| P28065 | PSMB9 | Proteasome subunit beta type-9 | T06792 | SwissTargetPrediction |
| P28062 | PSMB8 | Proteasome subunit beta type-8 | T77350 | SwissTargetPrediction |
| Q12866 | MERTK | Proto-oncogene tyrosine-protein kinase MER | T55781 | SwissTargetPrediction |
| P20248 | CCNA2 | CDK2/Cyclin A | T58470 | SwissTargetPrediction |
| P40337 | VHL | Von Hippel-Lindau disease tumor suppressor/Elongin B/Elongin C | T80423 | SwissTargetPrediction |
| Q9UQB9 | AURKC | Serine/threonine-protein kinase Aurora-C | T97592 | SwissTargetPrediction |
| O75908 | SOAT2 | Acyl coenzyme A:cholesterol acyltransferase 2 | T14463 | SwissTargetPrediction |
| P07288 | KLK3 | Prostate specific antigen | T36935 | SwissTargetPrediction |
| Q02643 | GHRHR | Growth hormone-releasing hormone receptor | T70449 | SwissTargetPrediction |
| P40306 | PSMB10 | 26S proteosome | T09022 | SwissTargetPrediction |
| O43683 | BUB1 | Mitotic checkpoint serine/threonine-protein kinase BUB1 | T20953 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T59328 | DI0030 | Angina pectoris | [ICD-11: BA40] | P00533 | EGFR |
| T59328 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P00533 | EGFR |
| T59328 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P00533 | EGFR |
| T59328 | DI0121 | Diabetic foot ulcer | [ICD-11: BD54] | P00533 | EGFR |
| T59328 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P00533 | EGFR |
| T59328 | DI0238 | Lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P00533 | EGFR |
| T59328 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P00533 | EGFR |
| T59328 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00533 | EGFR |
| T59328 | DI0420 | Unspecific body region injury | [ICD-11: ND56] | P00533 | EGFR |
| T77365 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P29274 | ADORA2A |
| T77365 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P29274 | ADORA2A |
| T77365 | DI0359 | Radionuclide imaging | [ICD-11: N.A.] | P29274 | ADORA2A |
| T92072 | DI0319 | Orthostatic hypotension | [ICD-11: BA21] | P30542 | ADORA1 |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T05031 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42338 | PIK3CB |
| T37848 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08684 | CYP3A4 |
| T62431 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P43405 | SYK |
| T83904 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q8IXJ6 | SIRT2 |
| T54771 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | P13866 | SLC5A1 |
| T54771 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P13866 | SLC5A1 |
| T54771 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P13866 | SLC5A1 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T76685 | DI0031 | Anorexia nervosa | [ICD-11: 6B80] | P21554 | CNR1 |
| T76685 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P21554 | CNR1 |
| T76685 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P21554 | CNR1 |
| T60631 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P07949 | RET |
| T60631 | DI0238 | Lung cancer | [ICD-11: 2C25] | P07949 | RET |
| T60631 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P07949 | RET |
| T60631 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P07949 | RET |
| T60631 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P07949 | RET |
| T60631 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P07949 | RET |
| T86679 | DI0180 | Herpes simplex infection | [ICD-11: 1F00] | P29275 | ADORA2B |
| T86679 | DI0397 | Supraventricular tachyarrhythmia | [ICD-11: BC81] | P29275 | ADORA2B |
| T09572 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q99705 | MCHR1 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T86837 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P17655 | CAPN2 |
| T48069 | DI0276 | Multiple structural anomalies syndrome | [ICD-11: LD2F] | P08069 | IGF1R |
| T48069 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P08069 | IGF1R |
| T48069 | DI0408 | Thyrotoxicosis | [ICD-11: 5A02] | P08069 | IGF1R |
| T56510 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | Q07817 | BCL2L1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T14597 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P04626 | ERBB2 |
| T14597 | DI0238 | Lung cancer | [ICD-11: 2C25] | P04626 | ERBB2 |
| T14597 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P04626 | ERBB2 |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T69991 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P30291 | WEE1 |
| T69991 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P30291 | WEE1 |
| T69991 | DI0429 | Uterine ligament/parametrium/uterine adnexa neoplasm | [ICD-11: 2C72] | P30291 | WEE1 |
| T65864 | DI0102 | Coronary atherosclerosis | [ICD-11: BA52] | Q16539 | MAPK14 |
| T65864 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q16539 | MAPK14 |
| T65864 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q16539 | MAPK14 |
| T65864 | DI0437 | Vitamin deficiency | [ICD-11: 5B55-5B5F] | Q16539 | MAPK14 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T85799 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P11802 | CDK4 |
| T85799 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11802 | CDK4 |
| T85799 | DI0351 | Psoriasis | [ICD-11: EA90] | P11802 | CDK4 |
| T87675 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | O14965 | AURKA |
| T87675 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14965 | AURKA |
| T82393 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P78536 | ADAM17 |
| T82393 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P78536 | ADAM17 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T76059 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P62942 | FKBP1A |
| T76059 | DI0349 | Pruritus | [ICD-11: EC90] | P62942 | FKBP1A |
| T76059 | DI0413 | Transplant rejection | [ICD-11: NE84] | P62942 | FKBP1A |
| T40149 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P24723 | PRKCH |
| T09826 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P11387 | TOP1 |
| T09826 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P11387 | TOP1 |
| T09826 | DI0238 | Lung cancer | [ICD-11: 2C25] | P11387 | TOP1 |
| T09826 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | P11387 | TOP1 |
| T09826 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11387 | TOP1 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T96623 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P08238 | HSP90AB1 |
| T96623 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08238 | HSP90AB1 |
| T96623 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P08238 | HSP90AB1 |
| T96623 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P08238 | HSP90AB1 |
| T96623 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P08238 | HSP90AB1 |
| T96623 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P08238 | HSP90AB1 |
| T96623 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P08238 | HSP90AB1 |
| T18477 | DI0015 | Acute upper respiratory infection | [ICD-11: CA07] | P07900 | HSP90AA1 |
| T18477 | DI0037 | Asthma | [ICD-11: CA23] | P07900 | HSP90AA1 |
| T20178 | DI0035 | Arterial occlusive disease | [ICD-11: BD40] | P01375 | TNF |
| T20178 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P01375 | TNF |
| T20178 | DI0351 | Psoriasis | [ICD-11: EA90] | P01375 | TNF |
| T20178 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P01375 | TNF |
| T99204 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P49810 | PSEN2 |
| T99204 | DI0380 | Shoulder lesion | [ICD-11: FB53] | P49810 | PSEN2 |
| T99204 | DI0390 | Soft tissue disorder | [ICD-11: FB56] | P49810 | PSEN2 |
| T99057 | DI0262 | Metastatic tumour | [ICD-11: 2D50-2E2Z] | Q02750 | MAP2K1 |
| T99057 | DI0336 | Phakomatoses/hamartoneoplastic syndrome | [ICD-11: LD2D] | Q02750 | MAP2K1 |
| T67849 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | O00329 | PIK3CD |
| T67849 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00329 | PIK3CD |
| T67849 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | O00329 | PIK3CD |
| T67849 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | O00329 | PIK3CD |
| T67849 | DI0395 | Stomach cancer | [ICD-11: 2B72] | O00329 | PIK3CD |
| T85943 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P12931 | SRC |
| T85943 | DI0220 | Ischemia | [ICD-11: 8B10-8B11] | P12931 | SRC |
| T85943 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P12931 | SRC |
| T85943 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P12931 | SRC |
| T92803 | DI0113 | Cytomegaloviral disease | [ICD-11: 1D82] | Q13627 | DYRK1A |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T78932 | DI0351 | Psoriasis | [ICD-11: EA90] | P29597 | TYK2 |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T14731 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q96EB6 | SIRT1 |
| T14731 | DI0399 | Systemic sclerosis | [ICD-11: 4A42] | Q96EB6 | SIRT1 |
| T14731 | DI0431 | Vasculitis | [ICD-11: 4A44] | Q96EB6 | SIRT1 |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T07173 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P04629 | NTRK1 |
| T07173 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04629 | NTRK1 |
| T44458 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P50750 | CDK9 |
| T44458 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P50750 | CDK9 |
| T44458 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50750 | CDK9 |
| T44458 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P50750 | CDK9 |
| T44458 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P50750 | CDK9 |
| T44458 | DI0302 | Non-alcoholic fatty liver disease | [ICD-11: DB92] | P50750 | CDK9 |
| T44458 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50750 | CDK9 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T15700 | DI0120 | Diabetes mellitus | [ICD-11: 5A10] | Q9UQ81 | MCH5 |
| T15700 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQ81 | MCH5 |
| T95913 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P48736 | PIK3CG |
| T95913 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P48736 | PIK3CG |
| T95913 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P48736 | PIK3CG |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T89360 | DI0413 | Transplant rejection | [ICD-11: NE84] | P12268 | IMPDH2 |
| T46937 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q9H244 | P2RY12 |
| T46937 | DI0405 | Thrombosis | [ICD-11: DB61-GB90] | Q9H244 | P2RY12 |
| T81735 | DI0360 | Rectum cancer | [ICD-11: 2B92] | P78527 | PRKDC |
| T81735 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P78527 | PRKDC |
| T17140 | DI0105 | Cough | [ICD-11: MD12] | P56373 | P2RX3 |
| T28330 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | P32238 | CCKAR |
| T28330 | DI0328 | Pancreatic malfunction | [ICD-11: DC30-DC3Z] | P32238 | CCKAR |
| T23787 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16875 | PFKFB3 |
| T14463 | DI0017 | Adrenal cancer | [ICD-11: 2D11] | O75908 | SOAT2 |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T86805 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P60842 | EIF4A1 |
| T17345 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P00374 | DHFR |
| T17345 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00374 | DHFR |
| T17345 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P00374 | DHFR |
| T17345 | DI0427 | Urinary tract infection | [ICD-11: GC08] | P00374 | DHFR |
| T52790 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P21452 | TACR2 |
| T10265 | DI0037 | Asthma | [ICD-11: CA23] | Q07343 | PDE4B |
| T10265 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q07343 | PDE4B |
| T10265 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | Q07343 | PDE4B |
| T66383 | DI0170 | Haemolytic anemia | [ICD-11: 3A20-3A2Z] | P00746 | CFD |
| T66383 | DI0365 | Retinopathy | [ICD-11: 9B71] | P00746 | CFD |
| T13075 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P48729 | CSNK1A1 |
| T13075 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P48729 | CSNK1A1 |
| T77350 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | P28062 | PSMB8 |
| T55781 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q12866 | MERTK |
| T55781 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | Q12866 | MERTK |
| T55781 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | Q12866 | MERTK |
| T55781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q12866 | MERTK |
| T58470 | DI0363 | Retina cancer | [ICD-11: 2D02] | P20248 | CCNA2 |
| T97592 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | Q9UQB9 | AURKC |
| T97592 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q9UQB9 | AURKC |
| T97592 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9UQB9 | AURKC |
| T14463 | DI0017 | Adrenal cancer | [ICD-11: 2D11] | O75908 | SOAT2 |
| T36935 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P07288 | KLK3 |
| T36935 | DI0346 | Prostate cancer | [ICD-11: 2C82] | P07288 | KLK3 |
| T36935 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P07288 | KLK3 |
| T70449 | DI0056 | Bone growth disorder | [ICD-11: FB86] | Q02643 | GHRHR |
| T70449 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | Q02643 | GHRHR |